NCT03709342View on ClinicalTrials.gov

A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

January 6, 2019

Primary Completion Date

March 7, 2019

Study Completion Date

June 7, 2019

Conditions

Acute Pancreatitis

Interventions

DRUG

CM4620-IE

single IV infusion on Day 1 over 4 hours

Trial Locations (1)

48202

Henry Ford Hospital, Detroit

Sponsors

Lead Sponsor

CalciMedica, Inc.

All Listed Sponsors

lead

CalciMedica, Inc.

INDUSTRY